Healthcare delivery has evolved to make home physiotherapy an available and effective option for various types of populations ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...

In 2025, Australian women are still suffering in silence. It's a confronting reality: 82 per cent of women feel they are the ...

Reports Q4 revenue $2.6M, consensus $3.35M.”With commercial preparations underway, we believe we are well positioned to launch TNX-102 SL for ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would ...

Chronic pain conditions accounted for 174,000 PIP claims in October 2024, a significant increase from October 2019, when ...

Among adults with chronic pain, clinical symptoms of depression were present in 39.3% and clinical symptoms of anxiety were present in 40.2%. (HealthDay News) — Approximately 40 percent of adults with ...

The blues and the jitters are very common among people battling chronic pain, a new evidence review says.About 40% of ...

A recently completed study found that certain terpenes in Cannabis sativa are effective at relieving post-surgical and fibromyalgia pain in preclinical models.

Terpenes from cannabis may relieve chronic pain without THC’s psychoactive effects. Researchers found that certain terpenes ...

Medication, physical therapy, steroid injections, and implanted devices may be helpful, but newer research has discovered ...

New research has identified cannabis-derived terpenes—compounds that give plants their distinctive aroma—as effective ...